biological source
rabbit
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
technique(s)
immunoprecipitation (IP): suitable, western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
ambient
target post-translational modification
unmodified
Quality Level
Gene Information
human ... FHIT(2272)
General description
Bis(5′-adenosyl)-triphosphatase (EC 3.6.1.29; UniProt P49789; also known as AP3A hydrolase, AP3Aase, Diadenosine 5′,5′′′-P1,P3-triphosphate hydrolase, Dinucleosidetriphosphatase, Fragile histidine triad protein) is encoded by the FHIT gene (Gene ID 2722) in human. Common fragile sites (CFSs) are large genomic loci that display chromosomal instability in response to genotoxic or replicative stress. Many CFSs harbor genes that contribute to cancer development and are non-randomly altered in cancers through genomic alteration. The Fragile histidine triad (FHIT) gene at FRA3B is one of the earliest and most frequently altered genes in the majority of human cancers. FHIT protein plays a role in apoptosis and prevention of the epithelial-mesenchymal transition (EMT). A FHIT-upregulated microRNA, miR-30c, has been identified to mediate the suppression of EMT and metastasis by directly targeting metastasis genes Metadherin (MTDH), High-mobility group AT-hook 2 (HMGA2), and the mesenchymal markers, Vimentin (VIM) and Fibronectin (FN1), in human lung cancer. In addition, FHIT protein also plays an important role in maintaining genome stability, loss of FHIT protein function leads to nucleotide imbalance, spontaneous replication stress, and DNA breaks. Because FHIT loss-induced DNA damage is checkpoint-independent, cells accumulate further DNA damage during subsequent cell cycles, accruing global genome instability that could facilitate oncogenic mutation acquisition and expedite clonal expansion.
~17 kDa observed. 16.86 kDa calculated. Uncharacterized bands may be observed in some lysate(s).
Immunogen
KLH-conjugated linear peptide corresponding to a C-terminal region sequence of human FHIT.
Application
Anti-FHIT, Cat. No. 07-172-I, is a highly specific rabbit polyclonal antibody that targets FHIT and has been tested in Immunoprecipitation and Western Blotting.
Immunoprecipitation Analysis: 5 µg from a representative lot immunoprecipited FHIT from 500 µg of A549 cell lysate.
Research Category
Epigenetics & Nuclear Function
Epigenetics & Nuclear Function
Biochem/physiol Actions
This rabbit polyclonal antibody targets a C-terminal epitope region outside the HIT domain.
Physical form
Affinity purified.
Purified rabbit polyclonal antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in A549 cell lysate.
Western Blotting Analysis: 0.2 µg/mL of this antibody detected FHIT in 10 µg of A549 cell lysate.
Western Blotting Analysis: 0.2 µg/mL of this antibody detected FHIT in 10 µg of A549 cell lysate.
Other Notes
Concentration: Please refer to lot specific datasheet.
Replaces: 07-172
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持